First of all, the good news is that the odds of a Hep C virus cure have increased to levels nearly 90% for Genotype 1 when the patient is prescribed one or more of the latest anti Hep C viral medicines now available.
With the latest medicines like Olysio, Sovaldi or Hepcinat, Harvoni, Daklinza, and Viekira Pak, the treatments have decreased the cure time to around three months.
As more advanced research and development increases among the pharmaceutical companies who compete for more effective and shorter duration of treatments for the Hep C infected, it is accurate to say that the future seems bright to see medications that shorten the treatment time and increase the cure rate.
This is very good news for people infected with the virus.
